Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Assets (2017 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Assets of $50.07 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 28.3% from $69.81 million a year earlier and down 24.9% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Assets (2017 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Assets of $66.65 million, down 7.4% from FY2025.

  • Annual Assets has declined for four straight fiscal years, though with a five-year compound annual growth rate of 1.3% (FY2021 to FY2026).
  • Across earlier fiscal years, Assets came in at $71.99 million in FY2025 (-1.8%), $73.3 million in FY2024 (-7.4%), $79.12 million in FY2023 (-38.5%) and $128.62 million in FY2022 (+105.9%).
  • The fiscal Q1 2027 figure is the lowest quarterly Assets since fiscal Q3 2021.
  • On a year-over-year basis, Assets rose in three of the last eight quarters, with an average decline of 7.5%.
  • Peak year-over-year performance for Assets in the last five years was growth of 766.1% in fiscal Q2 2022, against a decline of 41.5% in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $66.65 million (Q4 2026), $68.49 million (Q3 2026) and $66.58 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Grace Therapeutics 34.02 Mn -32.25 Mn - 50.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.07 Mn
Mar 31, 2026 66.65 Mn
Dec 31, 2025 68.49 Mn
Sep 30, 2025 66.58 Mn
Jun 30, 2025 69.81 Mn
Mar 31, 2025 71.99 Mn
Dec 31, 2024 61.22 Mn
Sep 30, 2024 65.35 Mn
Jun 30, 2024 69.72 Mn
Mar 31, 2024 73.30 Mn
Dec 31, 2023 76.19 Mn
Sep 30, 2023 78.21 Mn
Jun 30, 2023 73.03 Mn
Mar 31, 2023 79.12 Mn
Dec 31, 2022 116.80 Mn
Sep 30, 2022 120.91 Mn
Jun 30, 2022 124.93 Mn
Mar 31, 2022 128.62 Mn
Dec 31, 2021 114.23 Mn
Sep 30, 2021 119.80 Mn
API Access

Grace Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY